# Atara Biotherapeutics, Inc.: Form 8-K, filed Mar 10, 2023

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2023-03-10
- Accepted by EDGAR: Mar 10, 2023, 16:21 ET
- Period: 2023-03-10
- Accession: 0001193125-23-067628
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000119312523067628/d481537d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000119312523067628/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000119312523067628/d481537d8k.htm

Filed Mar 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-067628. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
